Luxxu Group Limited reported a marked improvement in its financial performance for the year ended 31 December 2025, narrowing net loss despite heavier provisions and a softer gross margin.
Revenue and Profitability – Revenue climbed 43.2% year-on-year to RMB 42.07 million, buoyed by stronger demand for branded watches and jewellery in Mainland China, which contributed RMB 37.96 million, while exhibition income fell to RMB 4.12 million. – Gross profit rose 29.0% to RMB 16.04 million; however, the gross margin eased to 38.1% from 42.4% as the higher-margin exhibition segment contracted. – Gains on financial assets at fair value swung to a profit of RMB 8.52 million (FY24: RMB 0.46 million loss), offsetting part of the burden from expected credit-loss provisions of RMB 13.53 million and inventory write-downs of RMB 5.12 million. – Selling and distribution expenses decreased 20.3% to RMB 5.52 million, while administrative costs held steady at RMB 19.60 million. – Finance costs inched up 6.2% to RMB 2.47 million, mainly stemming from bond interest and lease liabilities. – Net loss was reduced to RMB 21.69 million from RMB 51.96 million a year earlier; basic and diluted loss per share narrowed to 12.19 RMB cents (FY24: 47.12 RMB cents). The Board proposed no dividend.
Balance Sheet and Liquidity – Cash and cash equivalents rose to RMB 4.16 million (31 Dec 2024: RMB 1.03 million). – Net current assets stood at RMB 39.15 million, lifting the current ratio to 7.3x from 5.7x. – Total interest-bearing borrowings of RMB 21.40 million resulted in a gearing ratio of 82.0% (31 Dec 2024: 86.2%). – Inventories more than halved to RMB 9.26 million after a RMB 5.12 million write-down, while net trade receivables declined to RMB 7.98 million following a RMB 13.54 million ECL charge. – Net assets contracted to RMB 24.31 million (31 Dec 2024: RMB 33.90 million).
Capital Actions A capital reorganisation, effective 14 March 2025, consolidated every five HK$0.10 shares into one HK$0.50 share, followed by a reduction of par value to HK$0.01 and a subdivision of unissued shares. Subsequently, a 1-for-1 rights issue on 12 May 2025 raised net proceeds of approximately RMB 14.94 million, increasing issued shares to 215.65 million.
Investment Portfolio Financial assets at fair value through profit or loss reached RMB 23.40 million, equivalent to 45.1% of total assets. Key listed holdings include BFB Health (RMB 10.50 million), AMCO United Holding (RMB 6.72 million) and Capital VC (RMB 2.66 million).
Operational Focus and Outlook Management cites China’s 12.8% surge in gold, silver and jewellery retail sales and improving luxury demand as supportive factors. Efforts will centre on enhancing in-house design capabilities, expanding premium watch and jewellery offerings, and targeting the growing female consumer segment. The Group cautions that 2026 remains challenging amid broader economic uncertainties and plans to adjust its product mix accordingly.
Other Matters – No dividends declared for FY25. – No material acquisitions or disposals, capital commitments, or contingent liabilities reported post-year-end. – The company remained unhedged against foreign-exchange exposure and had no pledged assets.
The results have been reviewed by the Audit Committee and agreed by the external auditor, Jon Gepsom CPA Limited, with no modifications reported.